Loeb Partners Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-40,000
Closed 162
2018
Q2
$0 Hold
40,000
﹤0.01% 168
2018
Q1
$985K Hold
40,000
0.43% 60
2017
Q4
$1.07M Hold
40,000
0.32% 71
2017
Q3
$963K Hold
40,000
0.29% 77
2017
Q2
$858K Buy
+40,000
New +$807K 0.25% 91
2013
Q4
Sell
-52,000
Closed -$880K 200
2013
Q3
$880K Buy
+52,000
New +$875K 0.3% 86

Other funds holding NVO

Loeb Partners Corp's NVO Position: Q3 2018 in Review

Loeb Partners Corp sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 40,000 shares.

Loeb Partners Corp first reported a position in NVO in Q3 2013 and held it in 6 quarters. The position peaked at $1.07M in Q4 2017. 558 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

  • Loeb Partners Corp reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
  • Loeb Partners Corp sold 40,000 Novo Nordisk shares in Q3 2018.
  • Loeb Partners Corp first reported a position in Novo Nordisk in Q3 2013 and held it in 6 quarters.
  • Loeb Partners Corp's Novo Nordisk position peaked at $1.07M in Q4 2017.
  • 558 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on Loeb Partners Corp's 13F filing for Q3 2018, filed 9 Nov 2018.